We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Utah Medical Products
UTMD
$221M
| $668K | ﹤0.01% |
+9,398
| New | +$705K |
|
2852
Northwest Natural Holdings
NWN
$2.16B
| $665K | ﹤0.01% |
17,876
-34,330
| -66% | -$1.28M |
|
2853
PUT
Norfolk Southern
NSC
$77.5B
| $663K | ﹤0.01% |
2,600
-200
| -7% | -$49.5K |
|
2854
CALL
Alpha Metallurgical Resources
AMR
$1.84B
| $662K | ﹤0.01% |
2,000
-6,500
| -76% | -$2.38M |
|
2855
CALL
Guardant Health
GH
$19.3B
| $662K | ﹤0.01% |
+32,100
| New | +$688K |
|
2856
Paymentus
PAY
$3.89B
| $661K | ﹤0.01% |
+29,065
| New | +$524K |
|
2857
PUT
Ambarella
AMBA
$2.83B
| $660K | ﹤0.01% |
13,000
-19,700
| -60% | -$1.07M |
|
2858
Raymond James Financial
RJF
$33.1B
| $655K | ﹤0.01% |
5,102
+10
| +0.2% | +$1.17K |
|
|
SRG
2859
Seritage Growth Properties
SRG
$134M
| $655K | ﹤0.01% |
67,892
+14,931
| +28% | +$140K |
|
2860
PUT
iShares US Medical Devices ETF
IHI
$3.08B
| $650K | ﹤0.01% |
11,100
+7,200
| +185% | +$407K |
|
2861
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
| $649K | ﹤0.01% |
+16,356
| New | +$624K |
|
|
ZIMV
2862
DELISTED
ZimVie
ZIMV
| $649K | ﹤0.01% |
+39,337
| New | +$701K |
|
|
AKYA
2863
DELISTED
Akoya BioSciences
AKYA
| $649K | ﹤0.01% |
138,278
+41,346
| +43% | +$215K |
|
2864
Badger Meter
BMI
$3.74B
| $648K | ﹤0.01% |
+4,007
| New | +$615K |
|
|
DESP
2865
DELISTED
Despegar.com
DESP
| $648K | ﹤0.01% |
+54,184
| New | +$513K |
|
2866
Molina Healthcare
MOH
$10.6B
| $646K | ﹤0.01% |
1,573
-6
| -0.4% | -$2.33K |
|
2867
CGI
GIB
$14.6B
| $644K | ﹤0.01% |
5,830
+202
| +4% | +$22.6K |
|
|
RCM
2868
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
| $644K | ﹤0.01% |
50,000
+30,000
| +150% | +$349K |
|
2869
Invesco Mortgage Capital
IVR
$763M
| $644K | ﹤0.01% |
66,524
-74,415
| -53% | -$668K |
|
2870
nLIGHT
LASR
$3.78B
| $643K | ﹤0.01% |
49,491
+4,400
| +10% | +$57.7K |
|
|
AGNT
2871
AGNT Inc
AGNT
$698M
| $641K | ﹤0.01% |
62,095
+17,052
| +38% | +$209K |
|
2872
OrthoPediatrics
KIDS
$510M
| $641K | ﹤0.01% |
21,986
+10,304
| +88% | +$288K |
|
2873
Take-Two Interactive
TTWO
$44.7B
| $639K | ﹤0.01% |
4,300
+14
| +0.3% | +$2.17K |
|
2874
Interparfums
IPAR
$3.96B
| $636K | ﹤0.01% |
4,528
-17,266
| -79% | -$2.45M |
|
2875
Pacira BioSciences
PCRX
$1.04B
| $634K | ﹤0.01% |
+21,714
| New | +$667K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.